How does proprietary membrane protein expression technology support drug discovery?

Discovery Biology Services

}

Home / CRO Services / Discovery Biology Services / Discovery Biology Services detail

Time: 2026-07-14

Source: Viva Biotech

[Abstract]:

Viva Biotech’s proprietary membrane protein expression technology enables the successful production of challenging targets such as GPCRs and ion channels. Our platform combines optimized expression hosts, stabilizing fusion partners and mutations, detergent/nanodisc reconstitution, and conformation-locking strategies (e.g., nanobody co-complexing) to generate homogeneous, functionally active protein. This directly enables downstream applications — high-quality structure determination, SPR and other biophysical assays.

We have a membrane protein library covering 120+ GPCRs, 80+ transporters, and 50+ channels.

Previous Page：None... Next Page：Can the expressed protein be used directly for crystallography or Cryo-EM at Viva Biotech?

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.